Skip to main content
Top
Published in: Diabetologia 11/2008

01-11-2008 | Article

Perivascular fatty tissue at the brachial artery is linked to insulin resistance but not to local endothelial dysfunction

Authors: K. Rittig, K. Staib, J. Machann, M. Böttcher, A. Peter, F. Schick, C. Claussen, N. Stefan, A. Fritsche, H.-U. Häring, B. Balletshofer

Published in: Diabetologia | Issue 11/2008

Login to get access

Abstract

Aims/hypothesis

Different ectopic fat depots, such as visceral or hepatic fat, are known to affect whole body insulin sensitivity. It has recently been hypothesised that differences in perivascular adipose tissue (PVAT) mass around resistance vessels may also contribute to insulin resistance, possibly via direct vascular effects leading to reduced capillary cross-sectional area in the muscle, which in turn affects muscular blood flow and glucose uptake. Based on this, the aim of the present study was to test whether PVAT around conduit arteries (i.e. the brachial artery) influences NO bioavailability, expressed as flow-mediated dilation (FMD), or insulin sensitivity in humans in vivo.

Methods

Insulin sensitivity was measured by OGTT in all 95 participants (59 women, 36 men; median age 47 years, range 19–66 years) and by the gold standard, a euglycaemic–hyperinsulinaemic clamp, in a randomly selected subgroup of 33 participants. Quantification of the different fat compartments, including PVAT around the brachial artery, was achieved by high-resolution magnetic resonance imaging (1.5 T). Blood flow and FMD were measured at the brachial artery using high-resolution (13 MHz) ultrasound, after 5 min of forearm occlusion.

Results

PVAT was negatively correlated with insulin sensitivity and the post-ischaemic increase in blood flow. The association between PVAT and insulin sensitivity (r = −0.54, β = −0.37, p = 0.009) was independent of age, sex, visceral adipose tissue, liver fat, BMI and further cardiovascular risk factors. No correlation could be detected between PVAT and local endothelial function. However, we observed an independent association between PVAT and post-ischaemic increase in blood flow (r = −0.241; β = −1.69; p = 0.02).

Conclusions/interpretation

PVAT seems to play an independent role in the pathogenesis of insulin resistance. This may be due to direct vascular effects influencing muscular blood flow.
Literature
1.
2.
go back to reference Mohamed F, Monge JC, Gordon A et al (1995) Lack of role for nitric oxide (NO) in the selective destabilization of endothelial NO synthase mRNA by tumor necrosis factor-alpha. Arterioscler Thromb Vasc Biol 15:52–57PubMed Mohamed F, Monge JC, Gordon A et al (1995) Lack of role for nitric oxide (NO) in the selective destabilization of endothelial NO synthase mRNA by tumor necrosis factor-alpha. Arterioscler Thromb Vasc Biol 15:52–57PubMed
3.
go back to reference Zhang L, Wheatley CM, Richards SM et al (2003) TNF-alpha acutely inhibits vascular effects of physiological but not high insulin or contraction. Am J Physiol Endocrinol Metab 285:E654–E660PubMed Zhang L, Wheatley CM, Richards SM et al (2003) TNF-alpha acutely inhibits vascular effects of physiological but not high insulin or contraction. Am J Physiol Endocrinol Metab 285:E654–E660PubMed
4.
go back to reference Hotamisligil GS (1999) The role of TNFalpha and TNF receptors in obesity and insulin resistance. J Intern Med 245:621–625PubMedCrossRef Hotamisligil GS (1999) The role of TNFalpha and TNF receptors in obesity and insulin resistance. J Intern Med 245:621–625PubMedCrossRef
5.
go back to reference Baron AD, Tarshoby M, Hook G et al (2000) Interaction between insulin sensitivity and muscle perfusion on glucose uptake in human skeletal muscle: evidence for capillary recruitment. Diabetes 49:768–774PubMedCrossRef Baron AD, Tarshoby M, Hook G et al (2000) Interaction between insulin sensitivity and muscle perfusion on glucose uptake in human skeletal muscle: evidence for capillary recruitment. Diabetes 49:768–774PubMedCrossRef
7.
go back to reference Yudkin JS, Eringa E, Stehouwer CD (2005) ‘Vasocrine’ signalling from perivascular fat: a mechanism linking insulin resistance to vascular disease. Lancet 365:1817–1820PubMedCrossRef Yudkin JS, Eringa E, Stehouwer CD (2005) ‘Vasocrine’ signalling from perivascular fat: a mechanism linking insulin resistance to vascular disease. Lancet 365:1817–1820PubMedCrossRef
8.
go back to reference Khan AH, Pessin JE (2002) Insulin regulation of glucose uptake: a complex interplay of intracellular signalling pathways. Diabetologia 45:1475–1483PubMedCrossRef Khan AH, Pessin JE (2002) Insulin regulation of glucose uptake: a complex interplay of intracellular signalling pathways. Diabetologia 45:1475–1483PubMedCrossRef
9.
go back to reference Eringa EC, Stehouwer CD, Nieuw Amerongen GP et al (2004) Vasoconstrictor effects of insulin in skeletal muscle arterioles are mediated by ERK1/2 activation in endothelium. Am J Physiol Heart Circ Physiol 287:H2043–H2048PubMedCrossRef Eringa EC, Stehouwer CD, Nieuw Amerongen GP et al (2004) Vasoconstrictor effects of insulin in skeletal muscle arterioles are mediated by ERK1/2 activation in endothelium. Am J Physiol Heart Circ Physiol 287:H2043–H2048PubMedCrossRef
10.
go back to reference Rattigan S, Clark MG, Barrett EJ (1997) Hemodynamic actions of insulin in rat skeletal muscle: evidence for capillary recruitment. Diabetes 46:1381–1388PubMedCrossRef Rattigan S, Clark MG, Barrett EJ (1997) Hemodynamic actions of insulin in rat skeletal muscle: evidence for capillary recruitment. Diabetes 46:1381–1388PubMedCrossRef
11.
go back to reference Schafer S, Kantartzis K, Machann J et al (2007) Lifestyle intervention in individuals with normal versus impaired glucose tolerance. Eur J Clin Invest 37:535–543PubMedCrossRef Schafer S, Kantartzis K, Machann J et al (2007) Lifestyle intervention in individuals with normal versus impaired glucose tolerance. Eur J Clin Invest 37:535–543PubMedCrossRef
12.
go back to reference Matsuda M, DeFronzo RA (1999) Insulin sensitivity indices obtained from oral glucose tolerance testing: comparison with the euglycemic insulin clamp. Diabetes Care 22:1462–1470PubMedCrossRef Matsuda M, DeFronzo RA (1999) Insulin sensitivity indices obtained from oral glucose tolerance testing: comparison with the euglycemic insulin clamp. Diabetes Care 22:1462–1470PubMedCrossRef
13.
go back to reference Celermajer DS, Sorensen KE, Georgakopoulos D et al (1993) Cigarette smoking is associated with dose-related and potentially reversible impairment of endothelium-dependent dilation in healthy young adults. Circulation 88:2149–2155PubMed Celermajer DS, Sorensen KE, Georgakopoulos D et al (1993) Cigarette smoking is associated with dose-related and potentially reversible impairment of endothelium-dependent dilation in healthy young adults. Circulation 88:2149–2155PubMed
14.
go back to reference Joannides R, Haefeli WE, Linder L et al (1995) Nitric oxide is responsible for flow-dependent dilatation of human peripheral conduit arteries in vivo. Circulation 91:1314–1319PubMed Joannides R, Haefeli WE, Linder L et al (1995) Nitric oxide is responsible for flow-dependent dilatation of human peripheral conduit arteries in vivo. Circulation 91:1314–1319PubMed
15.
go back to reference Wendelhag I, Gustavsson T, Suurkula M, Berglund G, Wikstrand J (1991) Ultrasound measurement of wall thickness in the carotid artery: fundamental principles and description of a computerized analysing system. Clin Physiol 11:565–577PubMedCrossRef Wendelhag I, Gustavsson T, Suurkula M, Berglund G, Wikstrand J (1991) Ultrasound measurement of wall thickness in the carotid artery: fundamental principles and description of a computerized analysing system. Clin Physiol 11:565–577PubMedCrossRef
16.
go back to reference Machann J, Thamer C, Schnoedt B et al (2005) Standardized assessment of whole body adipose tissue topography by MRI. J Magn Reson Imaging 21:455–462PubMedCrossRef Machann J, Thamer C, Schnoedt B et al (2005) Standardized assessment of whole body adipose tissue topography by MRI. J Magn Reson Imaging 21:455–462PubMedCrossRef
17.
go back to reference Stefan N, Machicao F, Staiger H et al (2005) Polymorphisms in the gene encoding adiponectin receptor 1 are associated with insulin resistance and high liver fat. Diabetologia 48:2282–2291PubMedCrossRef Stefan N, Machicao F, Staiger H et al (2005) Polymorphisms in the gene encoding adiponectin receptor 1 are associated with insulin resistance and high liver fat. Diabetologia 48:2282–2291PubMedCrossRef
18.
go back to reference Hotamisligil GS (2003) Inflammatory pathways and insulin action. Int J Obes Relat Metab Disord 27(Suppl 3):S53–S55PubMedCrossRef Hotamisligil GS (2003) Inflammatory pathways and insulin action. Int J Obes Relat Metab Disord 27(Suppl 3):S53–S55PubMedCrossRef
19.
go back to reference Henrichot E, Juge-Aubry CE, Pernin A et al (2005) Production of chemokines by perivascular adipose tissue: a role in the pathogenesis of atherosclerosis? Arterioscler Thromb Vasc Biol 25:2594–2599PubMedCrossRef Henrichot E, Juge-Aubry CE, Pernin A et al (2005) Production of chemokines by perivascular adipose tissue: a role in the pathogenesis of atherosclerosis? Arterioscler Thromb Vasc Biol 25:2594–2599PubMedCrossRef
20.
go back to reference Baron AD, Steinberg HO, Chaker H et al (1995) Insulin-mediated skeletal muscle vasodilation contributes to both insulin sensitivity and responsiveness in lean humans. J Clin Invest 96:786–792PubMedCrossRef Baron AD, Steinberg HO, Chaker H et al (1995) Insulin-mediated skeletal muscle vasodilation contributes to both insulin sensitivity and responsiveness in lean humans. J Clin Invest 96:786–792PubMedCrossRef
21.
go back to reference Clark MG, Colquhoun EQ, Rattigan S et al (1995) Vascular and endocrine control of muscle metabolism. Am J Physiol 268:E797–E812PubMed Clark MG, Colquhoun EQ, Rattigan S et al (1995) Vascular and endocrine control of muscle metabolism. Am J Physiol 268:E797–E812PubMed
22.
go back to reference Hespel P, Vergauwen L, Vandenberghe K, Richter EA (1995) Important role of insulin and flow in stimulating glucose uptake in contracting skeletal muscle. Diabetes 44:210–215PubMedCrossRef Hespel P, Vergauwen L, Vandenberghe K, Richter EA (1995) Important role of insulin and flow in stimulating glucose uptake in contracting skeletal muscle. Diabetes 44:210–215PubMedCrossRef
23.
go back to reference Laakso M, Edelman SV, Brechtel G, Baron AD (1992) Impaired insulin-mediated skeletal muscle blood flow in patients with NIDDM. Diabetes 41:1076–1083PubMedCrossRef Laakso M, Edelman SV, Brechtel G, Baron AD (1992) Impaired insulin-mediated skeletal muscle blood flow in patients with NIDDM. Diabetes 41:1076–1083PubMedCrossRef
24.
go back to reference Vollenweider P, Randin D, Tappy L et al (1994) Impaired insulin-induced sympathetic neural activation and vasodilation in skeletal muscle in obese humans. J Clin Invest 93:2365–2371PubMedCrossRef Vollenweider P, Randin D, Tappy L et al (1994) Impaired insulin-induced sympathetic neural activation and vasodilation in skeletal muscle in obese humans. J Clin Invest 93:2365–2371PubMedCrossRef
25.
go back to reference Balletshofer BM, Haap M, Rittig K et al (2005) Early carotid atherosclerosis in overweight nondiabetic individuals is associated with subclinical chronic inflammation independent of underlying insulin resistance. Horm Metab Res 37:331–335PubMedCrossRef Balletshofer BM, Haap M, Rittig K et al (2005) Early carotid atherosclerosis in overweight nondiabetic individuals is associated with subclinical chronic inflammation independent of underlying insulin resistance. Horm Metab Res 37:331–335PubMedCrossRef
Metadata
Title
Perivascular fatty tissue at the brachial artery is linked to insulin resistance but not to local endothelial dysfunction
Authors
K. Rittig
K. Staib
J. Machann
M. Böttcher
A. Peter
F. Schick
C. Claussen
N. Stefan
A. Fritsche
H.-U. Häring
B. Balletshofer
Publication date
01-11-2008
Publisher
Springer-Verlag
Published in
Diabetologia / Issue 11/2008
Print ISSN: 0012-186X
Electronic ISSN: 1432-0428
DOI
https://doi.org/10.1007/s00125-008-1128-3

Other articles of this Issue 11/2008

Diabetologia 11/2008 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine